ライフサイエンスコーパス: LTA

1 LTA and its receptor TNFRSF14 are transcriptionally acti

2 LTA might be one way of increasing the power of genetic

3 LTA synthase (LtaS) polymerizes polyglycerol-phosphate f

4 LTA synthesis in Staphylococcus aureus and other microbe

5 LTA was a significant risk factor both for graft loss an

6 LTA was detected on the surface of 80% of the strains, a

7 LTA(4)H also possesses aminopeptidase activity with unkn

8 LTA(4)H knockdown limited the formation of leukotriene B

9 LTA-exposed T cells did not proliferate and did not prod

10 LTAs were recorded after a median of 9 days from hospita

11 against E. faecalis LTA also bind to type 1 LTA from other gram-positive species and opsonized Staph

12 at C-8, indicative of the formation of 14,15-LTA(4).

13 om 5-lipoxygenase(-/-) and leukotriene A(4) (LTA(4)) hydrolase(-/-) mice, we demonstrate that FLSs ge

14 there would be 240 SLK transplants and 9,426 LTAs.

15 ntly reduced 54 (Cowan), 38 (Wood), and 83% (LTA), whereas anti-CD14 alone significantly reduced 23,

16 donic acid hydroperoxide to a leukotriene A (LTA) type epoxide by specific lipoxygenase (LOX) enzymes

17 Abnormal LTA or ATP secretion test results were identified in 58%

18 rial cell wall components lipoteichoic acid (LTA) and peptidoglycan (PGN) induced similar expression

19 choic acid (TA) polymers, lipoteichoic acid (LTA) and wall teichoic acid (WTA), which are proposed to

20 e that is responsible for lipoteichoic acid (LTA) biosynthesis in Lactobacillus acidophilus (NCK2025)

21 that plays a key role in lipoteichoic acid (LTA) biosynthesis in Lactobacillus acidophilus NCFM (NCK

22 rived cell-wall component lipoteichoic acid (LTA) governs the second phase of immune responses when h

23 s peptidoglycan (PGN) and lipoteichoic acid (LTA) induced the secretion of proinflammatory mediators

24 e, we show that S. aureus lipoteichoic acid (LTA) inhibits platelet aggregation caused by physiologic

25 Lipoteichoic acid (LTA) is a Gram-positive cell surface molecule that is fo

26 Lipoteichoic acid (LTA) is a major component of the cell wall of Gram-posit

27 Lipoteichoic acid (LTA) is an important cell wall component of Gram-positiv

28 Lipoteichoic acid (LTA) is an important cell wall component required for pr

29 Lipoteichoic acid (LTA) is an important cell wall polymer found in gram-pos

30 Lipoteichoic acid (LTA) is an important cell wall polymer in Gram-positive

31 Type 1 lipoteichoic acid (LTA) is present in many clinically important gram-positi

32 aureus cell wall product lipoteichoic acid (LTA) may contribute to the development of inflammation a

33 (ATP) and the TLR2 ligand lipoteichoic acid (LTA) selectively and synergistically induced expression

34 by pulp fibroblasts under lipoteichoic acid (LTA) stimulation.

35 /6 agonist staphylococcal lipoteichoic acid (LTA) was abolished only in the index case individual, th

36 levan, and a glucosylated lipoteichoic acid (LTA) was identified in a micellar fraction.

37 Lipoteichoic acid (LTA), a cell wall polymer of gram-positive bacteria, con

38 Lipoteichoic acid (LTA), a cell wall ribitol polymer from Gram-positive org

39 Lipoteichoic acid (LTA), a glycerol phosphate polymer, is a component of th

40 fferentiation factor, and lipoteichoic acid (LTA), a Toll-like receptor 2 ligand.

41 . pneumoniae, TLR2 ligand lipoteichoic acid (LTA), and TLR4 ligand pneumolysin (PLY) stimulated BMDCs

42 popolysaccharide (LPS) or lipoteichoic acid (LTA), histones are released from the droplets and kill b

43 rt exposure times to LPS, lipoteichoic acid (LTA), thymidine homopolymer phosphorothioate oligonucleo

44 ll as S. aureus cell wall lipoteichoic acid (LTA), were incubated in thrombin-inhibited human whole b

45 ing SlpA, SlpB, SlpX, and lipoteichoic acid (LTA), which interact with pattern recognition receptors

46 ole in galactosylation of lipoteichoic acid (LTA).

47 opolysaccharide (LPS) and lipoteichoic acid (LTA).

48 ponents LPS, lipid A, and lipoteichoic acid (LTA).

49 ne or TLR-2 and S. aureus lipoteichoic acid (LTA).

50 ved cell wall components (lipoteichoic acid [LTA] and peptidoglycan [PGN]), which are essential for t

51 to membrane glycolipids (lipoteichoic acid, LTA).

52 The data show that the L. acidophilus LTA-negative in LTA (NCK2025) not only down-regulated IL

53 Lipoteichoic acids (LTA) are polymers of alternating units of a polyhydroxy

54 am-negative bacteria and lipoteichoic acids (LTA) from Gram-positive bacteria with host lipoprotein c

55 t, the membrane-anchored lipoteichoic acids (LTAs) do not show significant variation and do not contr

56 ipid-anchored TAs called lipoteichoic acids (LTAs) that bind and sequester the major autolysin LytA.

57 that both were atypical lipoteichoic acids (LTAs) with poly-(beta1->4)-ManNAc backbones substituted

58 to membrane glycolipids (lipoteichoic acids; LTA).

59 i, and staphylococci, and antibodies against LTA have been shown to opsonize nonencapsulated Enteroco

60 The effectiveness of rabbit antibody against LTA suggests that this conserved bacterial structure cou

61 Light transmission aggregometry (LTA) is used worldwide for the investigation of heritabl

62 ys included light transmission aggregometry (LTA), VerifyNow P2Y12 (VN), and vasodilator-associated s

63 ys included light transmission aggregometry (LTA), VerifyNow P2Y12 (VN-P2Y12), and vasodilator-associ

64 arison with light transmission aggregometry (LTA).

65 who received either liver transplant alone (LTA) or CLKT between 2002 and 2008.

66 and life years after liver transplant alone (LTA) or SLK transplant.

67 ion compared to liver transplantation alone (LTA) has also increased.

68 trate a critical role for lymphotoxin alpha (LTA) in the pathogenesis of Sjogren's disease in IL14alp

69 TNF -308G>A (rs1800629), lymphotoxin-alpha (LTA) 252A>G (rs909253), IL10 -3575T>A (rs1800890, rs1800

70 We identified lymphotoxin-alpha (LTA) as the causative factor for autocrine and paracrine

71 proinflammatory cytokine lymphotoxin-alpha (LTA) is thought to contribute to the pathogenesis of ath

72 and desorption in cation-free zeolites AlPO-LTA.

73 Although LTAs and WTAs are synthetically lethal, we report that t

74 ts and an increase of 4,971 life years among LTA recipients.

75 ide LTA synthases while YvgJ functions as an LTA primase, as indicated by the accumulation of a GroP-

76 a: OR(allelic) = 1.35, P(trend) = 0.004) and LTA 252G carriers (DLBCL: OR(allelic) = 1.12, P(trend) =

77 nding to CD36 of the complex CD36-TLR-2, and LTA independently bound to TLR-2.

78 l genes such as GZMB, PRF1, INFG, IL-32, and LTA, carbohydrate and lipid metabolism-related genes suc

79 Thermo nanoimprinting of LPS and LTA micelles to Epon 1002F films exhibits excellent sens

80 unt for the highly polar moieties of LPS and LTA, we evaluate different resist and stamp materials of

81 Using Optimul and LTA, concentration-response curves were generated for ar

82 WTA is made of sn-glycerol-3-phosphate, and LTA is made of sn-glycerol-1-phosphate.

83 ee cell wall glycopolymers rhamnan, PSP, and LTA, thus indicating that its function is shared by the

84 oposed to guide the decision between SLK and LTA, but their poor predictive value has limited their u

85 proteins as novel antimicrobial targets, and LTA mutant strains as improved probiotics are highlighte

86 These data suggested that Tet38 and LTA were independently involved in the invasion process.

87 element hHS-8 coordinately controls TNF and LTA gene expression in human T cells.

88 demonstrate significant reduction of TNF and LTA mRNA synthesis and of RNA polymerase II recruitment

89 human CD4(+) T cells, hHS-8 and the TNF and LTA promoters display increased H3K27 acetylation and nu

90 rovide an approach for modulation of TNF and LTA transcription in human disease using CRISPR/dCas9.

91 g Bacillus subtilis strain 168, both WTA and LTA are glycerolphosphate polymers yet are synthesized t

92 The differential cleavage of WTA and LTA by GlpQ reported here represents the first direct ev

93 fferences in stereochemistry between WTA and LTA have been suggested previously on the basis of diffe

94 InlB non-covalently adheres to both WTA and LTA, mediating its retention on the cell wall.

95 ogical and immunogenic properties of WTA and LTA.

96 can discriminate between B. subtilis WTA and LTA.

97 required, the numbers of SLK transplants and LTAs would be 648 and 9,065, respectively.

98 n, a tailoring modification of both WTAs and LTAs, becomes essential when the former, but not the lat

99 Anti-LTA mAb also rescued the macrophage response in mice lac

100 Thus, acquired anti-LTA Abs rescue TLR2-dependent immunity to staphylococcal

101 Combined TIRAP and anti-LTA Ab deficiencies underlie staphylococcal disease in t

102 se 4 (IRAK-4)-deficient individuals, by anti-LTA monoclonal antibody (mAb).

103 Addition of anti-LTA antibody to the bacteria prior to adding to A549 cel

104 6-fold less than RN6390 with or without anti-LTA antibody.

105 cologic interference of the large T antigen (LTA) may represent an effective therapeutic approach for

106 he GF microbiome's effect on MCs by applying LTA to the skin of GF mice.

107 c interval and life-threatening arrhythmias (LTA) are potential drug induced complications previously

108 iation measures of Linking Term Association (LTA), Minimum Weight Association (MWA), and Shared B to

109 In summary, we show that S. aureus LTA alone is sufficient to promote keratinocyte prolifer

110 owing a proinflammatory potency of S. aureus LTA.

111 the effects induced by intradermal S. aureus LTA.

112 nd indicates that pneumococcal and S. aureus LTAs differ not only in their structure but also in thei

113 in statistical power with long-term average (LTA) as compared to single-visit BP association studies.

114 nce, only a single conformer was found (BEA, LTA and MFI).

115 itioning of septa, suggesting a link between LTA synthesis and the cell division process.

116 unexpected discovery that cells lacking both LTAs and WTAs lose their ability to form Z rings and can

117 or-mediated inflammatory response induced by LTA plus PGN.

118 Median MPA by LTA for prasugrel 5 mg in LBW patients was noninferior t

119 vation of both the TLR2 and TLR4 pathways by LTA plus Hb leads to an enhanced innate immune response.

120 eMaR and ePD inhibited LTB(4) production by LTA(4) hydrolase.

121 within the dermis through SCF production by LTA-stimulated keratinocytes.

122 e genes that are most highly up-regulated by LTA plus Hb activation compared to LTA alone are cytokin

123 PD response by LTA, VN-P2Y12, and VASP during all treatments appeared s

124 The NGF secretion by LTA-stimulated pulp fibroblasts, which is negatively reg

125 L2 significantly increases BDNF secretion by LTA-stimulated pulp fibroblasts.

126 icated in the modulation of NGF secretion by LTA-stimulated pulp fibroblasts.

127 itive result was not always substantiated by LTA (specificity, 67%; positive predictive value, 77%).

128 l responses were significantly suppressed by LTA.

129 Assessment of LTA gene transcription by LTA promoter-luciferase construct indicated that LTA lev

130 in neutrophil clearance/apoptosis (C10orf54, LTA), adhesion (TNXB), or centrosome and microtubule str

131 14 Ab 18D11 significantly reduced 92 (Cowan, LTA) and 85% (Wood) of these markers.

132 g antibodies revealed that S. aureus-derived LTA and PGN-induced chemokine expression requires IL-1RI

133 ic monoclonal antibodies were used to detect LTA in the envelope of B. anthracis strain Sterne (pXO1(

134 review provides an overview of the different LTA types and their chemical structures and synthesis pa

135 e have concluded that the presence of either LTAs or WTAs on the cell surface is required for initiat

136 plained by modulation of the virally encoded LTA.

137 esistant or -sensitive) or their endotoxins (LTA + PGN) or exotoxins (TSST-1).

138 overall results render the copper-exchanged LTA zeolite attractive as a viable substitute for Cu-SSZ

139 lining-are competent to metabolize exogenous LTA(4) into LTB(4) ex vivo.

140 we show that antibodies against E. faecalis LTA also bind to type 1 LTA from other gram-positive spe

141 n with rabbit antibodies against E. faecalis LTA promoted the clearance of bacteremia by E. faecalis

142 ormations involving the framework types FAU, LTA, EMT, GIS, SOD, ANA, CAN, and JBW.

143 ting that these three proteins are bona-fide LTA synthases while YvgJ functions as an LTA primase, as

144 42, 249, and 16 genes were downregulated for LTA, LPS, Poly(dT), and Poly(I:C), respectively, with at

145 nce of posttransplantation RF was higher for LTA patients at 6 months and 3 years of follow-up (P<0.0

146 2-amine (ARM1) was published as a ligand for LTA(4)H with potential anti-inflammatory properties.

147 detection of 4 ng/mL for LPS and 2 ng/mL for LTA using a waveguide-based optical biosensor platform t

148 tative lipoteichoic acid ligase required for LTA assembly.

149 lycolipid production, and LtaS, required for LTA backbone synthesis, interact with one another.

150 138, 1013, and 22 genes were upregulated for LTA, LPS, Poly(dT), and Poly(I:C), and 12, 142, 249, and

151 The synthesis of LTB(4) and LTC(4) from LTA(4) are competitive, and MRP1 is the efflux pump for

152 Furthermore, LTA reduced hemostasis in a mouse tail-bleed assay.

153 Furthermore, LTA shapes the expression of cytokines, receptors, immun

154 s and phage adsorption, while galactosylated LTA plays no role thereof.

155 rast, trophic forms suppressed beta-glucan-, LTA-, and LPS-induced IL-1beta, IL-6, and TNFalpha produ

156 egative associations with the TNF haplotype, LTA+252A/TNFhtSNP1(-308)G/TNFhtSNP2(-238)G/TNFhtSNP3(+48

157 Hence, LTA is important for S. pneumoniae to establish systemic

158 onophagocytosis assays, suggesting that HN13 LTA is an attractive target for future vaccine-developme

159 ad modified with phosphoglycerol in the HN13 LTA.

160 ctivation of the leukotriene A(4) hydrolase (LTA(4)H) aminopeptidase (AP) activity with 4-methoxydiph

161 imilarities between the production of type I LTA and osmoregulated periplasmic glucans in gram-negati

162 The physiological functions of type I LTA are discussed in the context of inhibitors that bloc

163 ances in the biosynthesis pathway for type I LTA, d-alanylated polyglycerol-phosphate linked to di-gl

164 Our findings identify LTA(4)H as a functionally important target for mediating

165 s known on the effects of AMPK activation in LTA-triggered innate immune responses.

166 expressing a truncated P2Y(2)R deficient in LTA secretion.

167 twork connecting WTAs with genes involved in LTA synthesis, peptidoglycan synthesis, surface protein

168 We found that keratinocytes in LTA-treated skin were highly proliferative, expressing 1

169 show that the L. acidophilus LTA-negative in LTA (NCK2025) not only down-regulated IL-12 and TNFalpha

170 of FLNa in FLNa RNAi SMC rescued UTP-induced LTA expression.

171 Given that lipoproteins also inhibit LTA- and LPS-mediated inflammation, these results sugges

172 atidylglycerol binding to LtaS and inhibited LTA synthesis in S. aureus and in Escherichia coli expre

173 del of human pancreatic cancer by inhibiting LTA(4)H activity.

174 imply that therapeutic strategies inhibiting LTA(4)H to prevent LTB(4) generation may not reduce neut

175 In conclusion, AMPK activation inhibits LTA-induced lung inflammation in mice.

176 The LTA primase LtaP(Lm) initiates LTA synthesis by transferring the first glycerolphosphat

177 ver, although the ManNAc residues in JGS4143 LTA were phosphoethanolamine-modified, a few of these re

178 The JGS4143 LTA also had a terminal ribose and ManNAc instead of Man

179 In addition to inducing NF-kappaB, LTA promotes JAK2/STAT6 signaling.

180 ase growth triggers the degradation of a key LTA synthase, causing a switch to the production of wall

181 -hybrid approach, we show that the three key LTA synthesis proteins, YpfP and LtaA, involved in glyco

182 lot measuring LXB(4), and the arrow labeled 'LTA(4)H' should be aimed at the plot measuring LTB(4).

183 Pneumococcal mutants deficient in TacL lack LTA and show attenuated virulence in mouse models of acu

184 e individual, the only family member lacking LTA-specific antibodies (Abs).

185 S. aureus mutants lacking LTA are enlarged and show aberrant positioning of septa,

186 a substrate by 5-LO to form the initial LT, LTA(4).

187 ociated with a reduced expression of the MCV LTA as well as an increased expression of promyelocytic

188 d Rho activation and consequent Rho-mediated LTA secretion.

189 TLR2 and the generation of ROS/RNS mediates LTA-induced barrier dysfunction in PMEM.

190 oinflammatory role of LTA and the ability of LTA-deficient L. acidophilus to regulate inflammation an

191 ndicate that the mere presence or absence of LTA cannot account for cell division and sporulation def

192 Western blot analysis of LTA produced by ltaS(BS) , yfnI, yqgS and yvgJ single, t

193 Assessment of LTA gene transcription by LTA promoter-luciferase constr

194 Characterization of LTA mRNAs isolated from primary and from transformed hum

195 immune responses when high concentrations of LTA access T cells directly through disrupted skin.

196 The effect of LTA on lung endothelial permeability is not known.

197 We tested the effect of LTA on the internalization of S. aureus tet38 mutant QT7

198 kin barrier defects; however, the effects of LTA in vivo are not well understood.

199 type 1 antagonist ameliorated the effects of LTA, blocking neutrophil recruitment and increasing the

200 4) 3-fold without inducing the expression of LTA(4) hydrolase protein.

201 gttB are responsible for galactosylation of LTA and WTA respectively.

202 t predictors of QT-prolongation.Incidence of LTA during hospitalization was 3.6%.

203 s than bestatin, an established inhibitor of LTA(4)H activity, and the inhibitory effects of resverat

204 of modifier structure on enzyme kinetics of LTA(4)H, a series of analogues bearing structural featur

205 At low levels of LTA, the presence of Hb can result in a 200-fold increas

206 The occurrence and mechanisms of LTA modifications with D-alanyl, glycosyl, and phosphoch

207 on, tet38 affected growth in the presence of LTA inhibitor Congo red, with overexpression increasing

208 iene B(4) (LTB(4)), the enzymatic product of LTA(4)H, and suppressed anchorage-independent growth of

209 iver allograft and patient survival rates of LTA patients were significantly lower compared with CLKT

210 stimulates a strong and sustained release of LTA from WT but not P2Y(2)R(-/-) SMC.

211 activation signals on subsequent removal of LTA.

212 is study reveals the proinflammatory role of LTA and the ability of LTA-deficient L. acidophilus to r

213 Although the exact role of LTA is unknown, mutants display significant growth and p

214 g that P2Y(2)R/filamin-mediated secretion of LTA is independent of the endoplasmic reticulum/Golgi se

215 ause the skin microbiome is a rich source of LTA, a Toll-like receptor 2 ligand, we mimicked the GF m

216 the 2.8 angstrom X-ray crystal structure of LTA(4)H complexed with 4-OMe-ARM1, a 4MDM-ARM1 hybrid mo

217 that Tet38 can also protect the synthesis of LTA and WTA in S. aureus against their inhibitors, possi

218 Here we review four different types of LTA that can be distinguished on the basis of their chem

219 essary for Rho signaling pathway upstream of LTA release and subsequent stimulation of ICAM-1 express

220 The presence of D-alanine on LTA is necessary for the full inhibitory effect.

221 Research on LTA structure and function represents a large frontier t

222 ue transcript variants (TVs), including one (LTA TV8) that initiated within a polypyrimidine tract ne

223 r ltaS4 did not display defects in growth or LTA synthesis.

224 ns (in four loci) uniquely identified by our LTA analyses included those of SBP and MAP at 2p23 (rs12

225 sponded very poorly to all TLR2/6 (PAM2CSK4, LTA, FSL-1), TLR1/2 (PAM3CSK4), and TLR4 (LPS, MPLA) ago

226 enzyme responsible for polyglycerolphosphate LTA synthesis is LtaS, first described in Staphylococcus

227 o effect on IL-23 production, it potentiated LTA induced IL-23 production to the same level as that o

228 ing YfnI in the absence of LtaS(BS) produced LTA of retarded mobility, presumably caused by an increa

229 ggested by a structural analysis of purified LTA.

230 ied the potency of AMPK activation to reduce LTA-induced inflammation in vitro and in lungs in vivo.

231 In vivo, AMPK activation reduced LTA-induced neutrophil influx, as well as protein leak a

232 fter delivery of a monomeric ADP-ribosylase (LTA) and its pentameric carrier B subunit (LTB).

233 r ions when fully exchanged into high-silica LTA zeolites are demonstrated to exhibit excellent activ

234 Furthermore, local production of soluble LTA in the salivary glands of IL14alphaTG mice is necess

235 re the performance of the model with the STA/LTA, template matching, and FAST algorithms.

236 ue TLR2-dependent immunity to staphylococcal LTA in individuals with inherited TIRAP deficiency, acco

237 bility of exogenous nucleotides to stimulate LTA production was evaluated in VSMC by ELISA.

238 In addition, we found that UTP-stimulated LTA secretion is not sensitive to brefeldin A, which blo

239 th ltaS1 and ltaS2 were unable to synthesize LTA and exhibited reduced viability, altered envelope mo

240 anthracis employs LtaS enzymes to synthesize LTA, an envelope component that promotes bacterial growt

241 Therefore, D-alanine-tailored LTAs are required for survival when WTAs are absent.

242 ata provide a robust rationale for targeting LTA as a treatment strategy for cHL patients.

243 nservation (2 substitutions identified) than LTA allele variants (22 substitutions identified).

244 The decision to perform SLK rather than LTA is an important one because the benefits to the live

245 anges in platelet function more readily than LTA.

246 sistance to bacteriophage predation and that LTA galactosylation alters L. lactis resistance to bacte

247 We also demonstrate that LTA is increased in the salivary gland secretions and se

248 Finally, we determined that LTA-induced signals were mediated in part through IL-1,

249 We tested the hypothesis that LTA from Staphylococcus aureus induces alterations in th

250 promoter-luciferase construct indicated that LTA levels are controlled at the level of transcription.

251 ve bacteria are highlighted, indicating that LTA should perhaps be compared to these polymers rather

252 Furthermore, we observed that LTA caused damage to the skin barrier with substantial l

253 We observed that LTA potently suppressed T-lymphocyte activation in a Tol

254 co shape similarity algorithm predicted that LTA(4)H might be a potential target of resveratrol.

255 Here, we show that LTA exhibits a different linkage conformation compared t

256 les of human hematopoietic cells showed that LTA induces genes restricted to the lymphoid lineage, as

257 triple and the quadruple mutant, showed that LTA production was only abolished in the quadruple and t

258 The LTA downstream segment was found to be required for, and

259 The LTA primase LtaP(Lm) initiates LTA synthesis by transfer

260 ) subunit onto the glycolipid anchor and the LTA synthase LtaS(Lm) extends the polymer by the repeate

261 Interestingly, the LTA downstream segment alternate core promoter was activ

262 Additionally, modification of the LTA backbone structure can provide protection against ca

263 known to interfere with the function of the LTA.

264 ted against either novel heteroglycan or the LTA reduced bacterial load in mouse liver or kidney tiss

265 nt alternate core promoter that produces the LTA TV8 transcript most likely consists of a stimulating

266 Further investigation determined that the LTA downstream segment alternate core promoter that prod

267 ined PafR antagonist, demonstrating that the LTA inhibitory signal occurs via PafR.

268 fluorescence approach, we show here that the LTA polymer is not surface exposed in S. aureus, as it c

269 ociated haplotype (P = 0.00085), whereas the LTA+252AA/TNFhtSNP2GG haplotype was protective (P = 0.00

270 TFII-I, and RNA polymerase II) bind to this LTA region in vivo.

271 Thus LTA exposure resulted in temporary functional T-cell par

272 Thus, LTA sustains autocrine NF-kappaB activation, impacts act

273 The human TNF/LT locus genes TNF, LTA, and LTB are expressed in a cell type-specific manne

274 sensitivity and coordinate induction of TNF, LTA, and hHS-8 enhancer RNA transcription occurs.

275 we found that resveratrol directly bound to LTA(4)H in vitro and in cells and suppressed proliferati

276 e analyzed the direct exposure of T cells to LTA in vitro.

277 ulated by LTA plus Hb activation compared to LTA alone are cytokines, chemokines, receptors and inter

278 This finding was quite in contrast to LTA of the Staphylococcus aureus SA113Deltalgt mutant, w

279 In this study, the contribution to LTA transcriptional regulation of the region between the

280 hepatorenal syndrome, CLKT is preferable to LTA because it improves liver allograft and patient surv

281 nse to Cowan and Wood, and 12 in response to LTA.

282 ntrast, GlpQ could not degrade unsubstituted LTA unless it was partially precleaved, allowing access

283 Lastly, current efforts to use LTAs as vaccine candidates, synthesis proteins as novel

284 Using LTA analysis, we identified genetic loci influencing BP.

285 rate that detailed phenotypic analysis using LTA and ATP secretion is a powerful tool for the diagnos

286 As a result, the rate of SLK versus LTA differs significantly between transplant centers.

287 s of resveratrol were reduced in cells where LTA(4)H was suppressed by shRNA-mediated knockdown.

288 These data support a model whereby LTA backbone synthesis proceeds in S. aureus at the divi

289 n-beta mRNA is present after activation with LTA plus Hb, suggesting that the TRIF/TRAM-dependent pat

290 of IL-6 secretion following activation with LTA plus Hb.

291 evels increase upon platelet incubation with LTA, an effect which inhibits platelet activation.

292 Similar results were observed with LTA.

293 , which presented with normal responses with LTA.

294 ibitor, IkappaBalpha, after stimulation with LTA plus Hb.

295 Hemoglobin (Hb) can synergize with LTA, a TLR2 ligand, to potently activate macrophage inna

296 box 1 protein (HMGB1), which synergized with LTA to increase secretion of IL-6.

297 AMP-dependent pathways acted in synergy with LTA to enhance IL-23, only inhibition of the cAMP-depend

298 Treatment with LTA or the TLR2 agonist Pam((3))CSK((4)) induced signifi

299 Here we report that oral treatment with LTA-deficient NCK2025 normalizes innate and adaptive pat

300 show that self-assembly of colloidal zeolite LTA superball (ZAS) by tilted-angle sedimentation forms